OPEN END TURBO BULL OPTIONSSCHEIN - IPSEN | Real-time BOERSE MUENCHEN 12:45:05 08/07/2024 BST | ||
| 1.66 EUR | -4.60% |
|
| Current month | -13.00% | ||
| 1 month | -37.18% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
IPSEN
| Date | Price | Change |
|---|---|---|
| 08/07/24 | 1.66 | -4.60% |
| 05/07/24 | 1.74 | -13.00% |
| 04/07/24 | 2 | +8.70% |
| 03/07/24 | 1.84 | -2.65% |
| 02/07/24 | 1.89 | -6.44% |
Real-time BOERSE MUENCHEN
Last update July 08, 2024 at 12:45 pm
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | IPSEN |
| Issuer | 
UniCredit
|
| WKN | HC2SSG |
| ISIN | DE000HC2SSG5 |
| Date issued | 20/12/2022 |
| Strike | 96.45 € |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 1.32 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 4.05 € |
|---|---|
| Lowest since issue | 0.84 € |
| Spread | 0.05 € |
| Spread % | 2.94% |
Company Profile
Ipsen specialises in the research, development, manufacture and marketing of specialty medicines. Net sales by therapeutic area break down as follows:
- oncology (75.2%);
- neuroscience (21.1%);
- rare diseases (3.7%).
At the end of 2023, the group had 4 research and development centres located in France, the United Kingdom, the United States and China, and 4 manufacturing sites worldwide.
Net sales are distributed geographically as follows: Europe (40.2%), North America (33.3%) and other (26.5%).
Sector
-
Consensus: Ipsen
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
111.2
EUR
Average target price
127
EUR
Spread / Average Target
+14.17%
- Stock Market
- Certificates
- Certificat
